Dataset
LS513 Combination MTT Excel Files for SynergyFinder+ (Figure 5) Open Access Deposited
LS513 cells were treated with a combination of varying concentrations of MRTX1133 with varying concentrations of either afatinib, sapitinib, or pelitinib for 72 hours. Absorbances were normalized to DMSO control for % viability. The attached files were compiled in data format from n=2 data sets (6 data points total for each combination) and uploaded to SynergyFinder+ with % viability chosen as response.
- Alternate Title
- Synergy Graphs
- Creator
- License
- Subject
- Geographic Subject
- Submitter
- College
- Department
- Date Created
- Publisher
- Language
Digital Object Identifier (DOI)
Identifier: doi:10.7945/93c3-tn29
Link: https://doi.org/10.7945/93c3-tn29
This DOI link is the best way for others to cite your work.
-
- In Collection:
Relationships
Items
| Thumbnail | Title | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|
|
|
Synergyfinder_-_Combination_MRTX1133_Afatinib_MTT_LS513_Fig_5.xlsx | 2025-03-07 | Open Access |
|
|
|
Synergyfinder_-_Combination_MRTX1133_Pelitinib_MTT_LS513_Fig_5.xlsx | 2025-03-07 | Open Access |
|
|
|
Synergyfinder_-_Combination_MRTX1133_Sapitinib_MTT_LS513_Fig_5.xlsx | 2025-03-07 | Open Access |
|
Permanent link to this page: https://scholar.uc.edu/show/hq37vq09c